查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2158706

體外膜氧合（ECMO）市場：全球市場預測，2026-2032年

Extracorporeal Membrane Oxygenation Therapy Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外膜氧合 (ECMO) 市場將成長至 70.8 億美元，複合年成長率為 12.09%。

主要市場統計數據
基準年 2025 31.8億美元
預計年份：2026年 35.8億美元
預測年份 2032 70.8億美元
複合年成長率 (%) 12.09%

體外膜氧合（ECMO）：概述

體外膜氧合（ECMO）是一種先進的維生療法，可在常規治療無效時暫時輔助心臟、呼吸或心肺功能。靜脈-靜脈ECMO主要用於輔助治療嚴重呼吸衰竭，而靜脈-動脈ECMO則用於輔助治療循環衰竭和心源性休克。 ECMO的應用需要專用設備、多學科專家團隊、嚴格的監測、抗凝血治療的管理以及嚴格的患者選擇標準。

重症監護實務如何改變體外膜氧合（ECMO）的實施？

ECMO（體外膜氧合）的應用正從單純的救命措施發展成為高階重症監護方案中更具協作性的一部分。早期轉診、行動轉運計畫、模擬訓練、標準化方案、多學科決策以及結構化的撤機流程正在提高治療的一致性。同時，對於出血、血栓症、感染疾病、神經損傷、肢體缺血和迴路故障等併發症，嚴格的監測和品質改進仍然至關重要。

人工智慧正在增強體外膜氧合（ECMO）的監測和決策支援。

人工智慧 (AI) 可透過整合迴路數據、測試結果、影像、血流動力學和患者記錄，及早發現病情惡化並支持及時的臨床評估，從而改善體外膜氧合 (ECMO) 治療。潛在應用包括檢測異常壓力模式、預測氧合器故障、最佳化人工呼吸器和幫浦的設定以及輔助撤機評估。可靠的實施需要臨床檢驗的模型、代表性的資料集、可解釋的輸出、網路安全、互通性以及臨床醫生的監督。人工智慧應作為專家判斷的補充，而非替代。

區域趨勢：醫療資源取得差異與專業設施集中度

在北美，三級醫療機構覆蓋範圍廣，體外膜氧合（ECMO）計畫和轉診網路也已建立。同時，在加拿大和美國，基於註冊登記的品質改進和專業培訓仍然至關重要。在歐洲，除了成熟的計畫外，跨境病患轉診和指南制定工作也在進行中，但各國的醫療資源取得情況卻不盡相同。在亞太地區，澳洲、日本和韓國擁有高度發展的醫療體系，而中國和印度的醫療能力也迅速提升。在拉丁美洲，高階重症監護能力正在加強，但在設備、培訓和轉診系統方面仍面臨許多限制。在中東，對三級醫療機構和區域中心的投資正在推進，醫療資源主要集中在資源豐富的醫療體系中。非洲仍面臨專案覆蓋範圍有限、人員短缺、基礎設施不足以及需要精心規劃轉診和培訓模式等問題。

群體分析：聯盟和經濟區塑造能力建設

東南亞國協在三級醫療體系、資金籌措、訓練和轉診協調方面存在差異，體外膜氧合（ECMO）的準備情況也各不相同。金磚國家由成熟、開發中國家和醫療能力分佈不均的國家組成，它們優先考慮知識交流和人力資源發展。歐盟醫療體係受益於臨床合作和共用的專家網路，儘管各國在報銷機制和醫療能力方面存在差異。七國集團（G7）國家通常擁有先進的重症監護基礎設施和研究生態系統，而北約國家則可以利用其現有的緊急應變和醫療後勤架構。海灣合作理事會（GCC）國家正在發展先進的醫院能力和專科醫療服務，但醫療服務仍集中在主要都市區和轉診中心。

來自不同國家的見解：多種與體外膜氧合（ECMO）相容的模型

澳洲將專業的重症監護技術與地理位置優越的轉運和轉診網路結合。巴西和墨西哥正在擴大先進醫療服務的覆蓋範圍，同時努力解決區域差異和資源限制問題。加拿大和美國擁有完善的專科醫療基礎設施、成熟的轉診途徑和豐富的臨床經驗。中國和印度擁有覆蓋範圍廣、種類繁多的醫療網路，但不同地區和醫療機構的醫療服務可近性差異很大。法國、德國、義大利、西班牙和英國都受益於成熟的三級醫療網路，但其組織結構、報銷制度和區域可近性各不相同。日本和韓國擁有先進的醫院系統和專科項目。俄羅斯的醫療能力集中在主要城市，醫療服務的可近性和供給因地區而異。

領導者的首要任務：建構可靠且公平的體外膜氧合（ECMO）治療路徑

行業領導者應優先考慮可互通的迴路和監測系統、以臨床醫生為中心的分析以及基於循證醫學的誘導、抗凝血治療、轉運、併發症管理和插管移除方案。與醫院和專業協會的合作可以支援模擬訓練、認證、註冊登記和上市後安全監測。製造商和供應商在設計時應考慮可維護性、員工易用性、網路安全和資源受限的環境。醫療系統應加強轉診網路，建立區域性體外膜氧合（ECMO）中心，透明地評估治療結果，並投資於滿足當地社區需求的解決方案，而不是在缺乏協調的情況下集中資源。

調查方法：基於證據的體外膜氧合（ECMO）治療評估

本執行摘要採用結構化的定性評估方法對體外膜氧合（ECMO）療法進行分析，涵蓋臨床實踐模式、醫療服務需求、技術發展、區域醫療體系特徵以及國家層面的基礎設施等因素。研究結果是基於已記錄的臨床和營運實際情況，而非市場預測。該分析區分了已確立的應用案例和新興機遇，避免了未經證實的數字論斷，並認知到即使在同一區域內的不同醫療機構，其治療機會、治療效果和應對能力也可能存在顯著差異。

結論：永續卓越需要人脈、技能和管治。

ECMO仍然是一種高度複雜的治療方法，其價值取決於及時篩選患者、經驗豐富的團隊、可靠的設備以及協調的長期護理。未來的發展將受到區域網路設計、人力資源開發、互通性、安全管治以及人工智慧合理應用的影響。當醫療系統將專家知識與公平的轉診途徑、透明的品質評估和持續學習相結合時，才能取得最大的進展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 體外膜氧合療法（ECMO）市場：依類型分類

  • 靜脈-動脈型
  • 靜脈-靜脈型

第8章 體外膜氧合（ECMO）市場：依產品分類

  • 配件
  • 套管
  • 氧合器
  • 泵浦
  • 管道

第9章 體外膜氧合（ECMO）市場：依病患年齡分類

  • 成人
  • 新生
  • 兒童

第10章 體外膜氧合（ECMO）市場：依醫院類型分類

  • 心臟護理中心
  • 兒童及新生兒專科醫院
    • 新生兒護理醫院
    • 兒童醫院
  • 三級醫療醫院

第11章 體外膜氧合（ECMO）市場：依應用領域分類

  • 心
  • 體外心肺復甦術（CPR）
  • 呼吸系統

第12章 體外膜氧合（ECMO）市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 體外膜氧合（ECMO）市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 體外膜氧合療法（ECMO）市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Abiomed, Inc.
  • ALung Technologies, Inc.
  • Andocor NV
  • Braile Biomedica Industria e Comercio SA
  • Breethe, Inc.
  • Chalice Medical Ltd.
  • EUROSETS Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OriGen Biomedical, Inc.
  • Senko Medical Instrument Manufacturing Co., Ltd.
  • Spectrum Medical Limited
  • Terumo Corporation
  • Xenios AG

第17章 主要專家

Product Code: MRR-4654A89DBB9D

The Extracorporeal Membrane Oxygenation Therapy Market is projected to grow by USD 7.08 billion at a CAGR of 12.09% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.18 billion
Estimated Year [2026] USD 3.58 billion
Forecast Year [2032] USD 7.08 billion
CAGR (%) 12.09%

Extracorporeal Membrane Oxygenation Therapy: Executive Overview

Extracorporeal membrane oxygenation (ECMO) is an advanced life-support therapy that temporarily supports cardiac, respiratory, or combined cardiopulmonary function when conventional treatment is insufficient. Venovenous ECMO primarily supports severe respiratory failure, while venoarterial ECMO supports circulatory failure and cardiogenic shock. Its use requires specialized equipment, multidisciplinary expertise, intensive monitoring, anticoagulation management, and carefully defined patient-selection criteria.

How Critical-Care Practice Is Transforming ECMO Delivery

ECMO practice is evolving from a rescue-only intervention toward a more coordinated component of advanced critical-care pathways. Earlier referral, mobile retrieval programs, simulation-based training, standardized protocols, multidisciplinary decision-making, and structured weaning practices are improving the consistency of care. At the same time, complications including bleeding, thrombosis, infection, neurological injury, limb ischemia, and circuit failure continue to require rigorous surveillance and quality improvement.

Artificial Intelligence Is Strengthening ECMO Monitoring and Decision Support

Artificial intelligence can enhance ECMO care by integrating circuit data, laboratory results, imaging, hemodynamics, and patient records to identify deterioration and support timely clinical review. Potential applications include detecting abnormal pressure patterns, anticipating oxygenator dysfunction, optimizing ventilator and pump settings, and supporting weaning assessments. Reliable deployment depends on clinically validated models, representative datasets, explainable outputs, cybersecurity, interoperability, and clinician oversight; AI should augment rather than replace specialist judgment.

Regional Insights: Uneven Access and Specialized-Center Concentration

North America has extensive access to tertiary hospitals, established ECMO programs, and referral networks, while Canada and the United States continue to emphasize registry-based quality improvement and specialized training. Europe combines mature programs with cross-border referral and guideline development, although access varies across countries. Asia-Pacific includes highly developed systems in Australia, Japan, and South Korea alongside rapidly expanding capabilities in China and India. Latin America is strengthening advanced critical-care capacity but faces equipment, training, and referral constraints. The Middle East is investing in tertiary hospitals and regional centers, with access concentrated in more resourced health systems. Africa remains characterized by limited program availability, workforce shortages, infrastructure constraints, and the need for carefully prioritized referral and training models.

Group Insights: Alliances and Economic Blocs Shape Capability Building

ASEAN countries show varied ECMO readiness, with differences in tertiary-care capacity, financing, training, and referral coordination. BRICS members span mature, developing, and unevenly distributed capabilities, making knowledge exchange and workforce development important priorities. European Union systems benefit from shared clinical collaboration and professional networks, although national reimbursement and capacity differ. G7 countries generally possess strong critical-care infrastructure and research ecosystems, while NATO members may also draw on established emergency-response and medical logistics frameworks. GCC states are building advanced hospital capacity and specialist services, but access remains concentrated in major urban centers and referral hubs.

Country Insights: Diverse Models of ECMO Readiness

Australia combines specialized critical-care expertise with geographically important retrieval and referral capabilities. Brazil and Mexico are expanding advanced-care access while managing regional disparities and resource constraints. Canada and the United States have broad specialist infrastructure, established referral pathways, and substantial clinical experience. China and India are developing capacity across large and diverse health systems, with access varying significantly by location and institution. France, Germany, Italy, Spain, and the United Kingdom benefit from mature tertiary-care networks, though organization, reimbursement, and regional availability differ. Japan and South Korea maintain sophisticated hospital systems and specialist programs. Russia's capabilities are concentrated in major centers, with access and supply conditions varying across regions.

Priorities for Leaders: Build Reliable, Equitable ECMO Pathways

Industry leaders should prioritize interoperable circuit and monitoring systems, clinician-centered analytics, and evidence-based protocols for initiation, anticoagulation, transport, complication management, and decannulation. Partnerships with hospitals and professional societies can support simulation training, credentialing, registries, and post-market safety surveillance. Manufacturers and providers should design for maintainability, staff usability, cybersecurity, and constrained-resource settings. Health systems should strengthen referral networks, define regional ECMO hubs, evaluate outcomes transparently, and align investment with population need rather than concentrating capability without coordinated access.

Research Methodology: Evidence-Based Assessment of ECMO Therapy

This executive summary uses a structured qualitative assessment of ECMO therapy, including clinical practice patterns, care-delivery requirements, technology developments, regional health-system characteristics, and country-level infrastructure considerations. Findings are framed around documented clinical and operational realities rather than market estimates. The analysis distinguishes established applications from emerging opportunities, avoids unsupported numerical claims, and recognizes that access, outcomes, and readiness can vary substantially between institutions within the same geography.

Conclusion: Sustainable Excellence Requires Networks, Skills, and Governance

ECMO remains a high-complexity intervention whose value depends on timely patient selection, experienced teams, dependable equipment, and coordinated longitudinal care. The next phase of development will be shaped by regional network design, workforce development, interoperability, safety governance, and responsible use of AI. Progress will be strongest where health systems combine specialized expertise with equitable referral pathways, transparent quality measurement, and continuous learning.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Extracorporeal Membrane Oxygenation Therapy Market, by Type

  • 7.1. Introduction
  • 7.2. Venoarterial
  • 7.3. Venovenous

8. Extracorporeal Membrane Oxygenation Therapy Market, by Product

  • 8.1. Introduction
  • 8.2. Accessories
  • 8.3. Cannula
  • 8.4. Oxygenator
  • 8.5. Pump
  • 8.6. Tubing

9. Extracorporeal Membrane Oxygenation Therapy Market, by Patient Age

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Neonatal
  • 9.4. Pediatric

10. Extracorporeal Membrane Oxygenation Therapy Market, by Hospital Type

  • 10.1. Introduction
  • 10.2. Cardiac Care Centers
  • 10.3. Pediatric And Neonatal Care Hospitals
    • 10.3.1. Neonatal Care Hospitals
    • 10.3.2. Pediatric Care Hospitals
  • 10.4. Tertiary Care Hospitals

11. Extracorporeal Membrane Oxygenation Therapy Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiac
  • 11.3. Extracorporeal Cardiopulmonary Resuscitation
  • 11.4. Respiratory

12. Extracorporeal Membrane Oxygenation Therapy Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Extracorporeal Membrane Oxygenation Therapy Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Extracorporeal Membrane Oxygenation Therapy Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Abiomed, Inc.
  • 16.3. ALung Technologies, Inc.
  • 16.4. Andocor N.V.
  • 16.5. Braile Biomedica Industria e Comercio S.A.
  • 16.6. Breethe, Inc.
  • 16.7. Chalice Medical Ltd.
  • 16.8. EUROSETS S.r.l.
  • 16.9. Fresenius Medical Care AG & Co. KGaA
  • 16.10. Getinge AB
  • 16.11. Hemovent GmbH
  • 16.12. LivaNova PLC
  • 16.13. Medtronic plc
  • 16.14. MicroPort Scientific Corporation
  • 16.15. Nipro Corporation
  • 16.16. OriGen Biomedical, Inc.
  • 16.17. Senko Medical Instrument Manufacturing Co., Ltd.
  • 16.18. Spectrum Medical Limited
  • 16.19. Terumo Corporation
  • 16.20. Xenios AG

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Extracorporeal Membrane Oxygenation Therapy Market, Years Considered for the Study
  • FIGURE 2. Global Extracorporeal Membrane Oxygenation Therapy Market, Research Design
  • FIGURE 3. Global Extracorporeal Membrane Oxygenation Therapy Market, Research Framework
  • FIGURE 4. Global Extracorporeal Membrane Oxygenation Therapy Market, Data Triangulation
  • FIGURE 5. Global Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2025 vs 2032 (%)
  • FIGURE 9. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2025 vs 2032 (%)
  • FIGURE 11. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2025 vs 2032 (%)
  • FIGURE 13. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 15. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Extracorporeal Membrane Oxygenation Therapy Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Extracorporeal Membrane Oxygenation Therapy Market Segmentation & Coverage
  • TABLE 2. Global Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 4. Global Venoarterial Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Venoarterial Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Venoarterial Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Venovenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Venovenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Venovenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 11. Global Accessories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Accessories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Accessories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Cannula Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Cannula Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Cannula Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Oxygenator Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Pump Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Pump Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Pump Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Tubing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Tubing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Tubing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 27. Global Adult Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Adult Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Adult Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 37. Global Cardiac Care Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Cardiac Care Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Cardiac Care Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Pediatric And Neonatal Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Pediatric And Neonatal Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Pediatric And Neonatal Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Neonatal Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Neonatal Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Neonatal Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Pediatric Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Pediatric Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Pediatric Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Tertiary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Tertiary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Tertiary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 53. Global Cardiac Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Cardiac Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Cardiac Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Extracorporeal Cardiopulmonary Resuscitation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Extracorporeal Cardiopulmonary Resuscitation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Extracorporeal Cardiopulmonary Resuscitation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 69. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 70. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 72. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 73. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 74. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 75. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 76. North America Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 77. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 79. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 80. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 81. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 82. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 83. Latin America Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 84. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 86. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 87. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 88. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 89. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 90. Europe Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 91. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 93. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 94. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 95. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 96. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 97. Middle East Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 98. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 100. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 101. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 102. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 103. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 104. Africa Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 105. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 108. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 109. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 112. ASEAN Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 113. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 115. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 116. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 117. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 118. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 119. GCC Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 120. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 122. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 123. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 124. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 125. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 126. European Union Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 127. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 129. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 130. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 131. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 132. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 133. BRICS Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 134. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 136. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 137. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 138. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 139. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 140. G7 Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 141. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 143. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 144. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 145. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 146. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 147. NATO Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 148. Global Extracorporeal Membrane Oxygenation Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 149. United States Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 150. United States Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 151. United States Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 152. United States Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 153. United States Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 154. United States Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 155. United States Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 156. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 157. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 158. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 159. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 160. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 161. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 162. Canada Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 163. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 164. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 165. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 166. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 167. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 168. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 169. Mexico Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 170. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 171. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 172. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 173. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 174. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 175. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 176. Brazil Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 177. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 178. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 179. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 180. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 181. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 182. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 183. United Kingdom Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 184. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 185. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 186. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 187. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 188. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 189. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 190. Germany Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 191. France Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 192. France Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 193. France Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 194. France Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 195. France Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 196. France Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 197. France Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 198. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 199. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 200. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 201. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 202. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 203. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 204. Russia Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 205. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 206. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 207. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 208. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 209. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 210. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 211. Italy Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 212. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 213. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 214. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 215. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 216. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 217. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 218. Spain Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 219. China Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 220. China Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 221. China Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 222. China Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 223. China Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 224. China Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 225. China Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 226. India Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 227. India Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 228. India Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 229. India Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 230. India Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 231. India Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 232. India Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 233. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 234. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 235. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 236. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 237. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 238. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 239. Japan Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 240. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 241. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 242. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 243. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 244. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 245. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 246. Australia Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 247. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 248. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 249. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, by Product, 2017-2032 (USD Million)
  • TABLE 250. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, by Patient Age, 2017-2032 (USD Million)
  • TABLE 251. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, by Hospital Type, 2017-2032 (USD Million)
  • TABLE 252. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, by Pediatric And Neonatal Care Hospitals, 2017-2032 (USD Million)
  • TABLE 253. South Korea Extracorporeal Membrane Oxygenation Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 254. Global Extracorporeal Membrane Oxygenation Therapy Market Share, by Key Player, 2025
  • TABLE 255. Global Extracorporeal Membrane Oxygenation Therapy Market, Key Experts